JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M509567200 on October 27, 2005

J. Biol. Chem., Vol. 281, Issue 1, 626-637, January 6, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/1/626    most recent
M509567200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brummer, T.
Right arrow Articles by Daly, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brummer, T.
Right arrow Articles by Daly, R. J.

Increased Proliferation and Altered Growth Factor Dependence of Human Mammary Epithelial Cells Overexpressing the Gab2 Docking Protein*

Tilman Brummer1, Daniel Schramek12, Vanessa M. Hayes3, Haley L. Bennett4, C. Elizabeth Caldon5, Elizabeth A. Musgrove3, and Roger J. Daly6

From the Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia

The docking protein Gab2 is a proto-oncogene product that is overexpressed in primary breast cancers. To determine the functional consequences of Gab2 overexpression, we utilized the immortalized human mammary epithelial cell line MCF-10A. In monolayer culture, expression of Gab2 at levels comparable with those detected in human breast cancer cells accelerated epidermal growth factor (EGF)-induced cell cycle progression and was associated with increased basal Stat5 tyrosine phosphorylation and enhanced and/or more sustained EGF-induced Erk and Akt activation. Three-dimensional Matrigel culture of MCF-10A cells resulted in the formation of polarized, growth-arrested acini with hollow lumina. Under these conditions, Gab2 increased cell proliferation during morphogenesis, leading to significantly larger acini, an effect dependent on Gab2 binding to Grb2 and Shp2 and enhanced by recruitment of the p85 subunit of phosphatidylinositol 3-kinase. Pharmacological inhibition of MEK revealed that, in addition to direct activation of phosphatidylinositol 3-kinase, increased Erk signaling also contributed to Gab2-mediated enhancement of acinar size. In addition, Gab2 overcame the proliferative suppression that normally occurs in late stage cultures and conferred independence of the morphogenetic program from exogenous EGF. Finally, higher levels of Gab2 expression led to the formation of large disorganized structures with defective luminal clearance. These findings support a role for Gab2 in mammary tumorigenesis.


Received for publication, August 31, 2005 , and in revised form, October 18, 2005.

* This work was supported in part by Department of Defense Breast Cancer Research Program Grant DAMD17-00-1-0251 and by grants from the National Health and Medical Research Council of Australia, the Cancer Council NSW, and the Association for International Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 Recipient of an Endeavor Australian postgraduate research fellowship.

3 Cancer Institute NSW Fellow.

4 Recipient of an Australian postgraduate award.

5 Cancer Institute NSW Scholar and recipient of an Australian postgraduate award.

6 To whom correspondence should be addressed: Cancer Research Program, Garvan Inst. of Medical Research, 384 Victoria St., Sydney, New South Wales 2010, Australia. Tel.: 61-2-9295-8333; Fax: 61-2-9295-8321; E-mail: r.daly{at}garvan.org.au.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. E. Caldon, A. Swarbrick, C. S.L. Lee, R. L. Sutherland, and E. A. Musgrove
The Helix-Loop-Helix Protein Id1 Requires Cyclin D1 to Promote the Proliferation of Mammary Epithelial Cell Acini
Cancer Res., April 15, 2008; 68(8): 3026 - 3036.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. J. Galliher-Beckley and W. P. Schiemann
Grb2 binding to Tyr284 in T{beta}R-II is essential for mammary tumor growth and metastasis stimulated by TGF-{beta}
Carcinogenesis, February 1, 2008; 29(2): 244 - 251.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Zhang, E. Diaz-Flores, G. Li, Z. Wang, Z. Kang, E. Haviernikova, S. Rowe, C.-K. Qu, W. Tse, K. M. Shannon, et al.
Abnormal hematopoiesis in Gab2 mutant mice
Blood, July 1, 2007; 110(1): 116 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yu, J. Luo, W. Yang, Y. Wang, M. Mizuki, Y. Kanakura, P. Besmer, B. G. Neel, and H. Gu
The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway
J. Biol. Chem., September 29, 2006; 281(39): 28615 - 28626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.